[Our experience in the treatment of acute lymphoblastic leukemias (ALL) having different risk levels with the BFM-83 therapeutic protocol]

An Esp Pediatr. 1988 Oct:29 Suppl 34:68-72.
[Article in Spanish]
No abstract available

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Child
  • Child, Preschool
  • Clinical Protocols
  • Female
  • Humans
  • Infant
  • Male
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Risk Factors

Substances

  • Antineoplastic Agents